a phase II trial of amrubicin and carboplatin for patients with extensive stage small cell lung cancer
Phase of Trial: Phase II
Latest Information Update: 01 Sep 2014
At a glance
- Drugs Amrubicin (Primary) ; Carboplatin (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 07 May 2008 New trial record.